NextCell Pharma ABNXTCL 
$0.16-2.40%24h
-2.40%24h
Global rank34314
Market cap$5.49M
Change 7d27.34%
YTD Performance-38.02%
SP500 benchmarkUnderperform
P/E-0.14
P/S5.54
Revenue$990.69K
Earnings-$3.90M
Dividend yield-
Main Sector
Healthcare
Category
NextCell Pharma AB (NXTCL) Cash on Hand
NXTCL Cash on Hand in 2022: $4.90M
According to NextCell Pharma AB latest financial reports the cash on hand of NXTCL is $4.90M, an decrease of -48.49% to 2022. At the end of 2022 company had $9.51M cash on hand. This amount reflects the liquid assets available to the company, which are crucial for its operational flexibility, investment opportunities, and overall financial security.
NXTCL Cash on Hand History from 2018 to 2023
-
Value:-
NXTCL Cash on Hand by year
| Year | Cash on Hand | Change |
|---|---|---|
| 2023 | $4.90M | -48.49% |
| 2022 | $9.51M | -30.22% |
| 2021 | $13.63M | 533.78% |
| 2020 | $2.15M | 9.09% |
| 2019 | $1.97M | 545.99% |
| 2018 | $305.22K | - |
View the Top Cash on Hand Companies 
